Twist Bioscience Stock Forecast
NASDAQ: TWSTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 8, 11:37 AM ET
TWST analyst consensus
Consensus (13 analysts)
buy
Avg. price target
$133.75-11.17%
- Strong buy 2
- Buy 7
- Hold 3
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 13 Wall Street analysts covering Twist Bioscience (2026-10-07), 9 rate the stock a buy or strong buy, 3 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $133.75, with a high estimate of $215.00 and a low estimate of $36.00. The average target implies downside of 11.2% from the current price of $150.57.
The spread between the highest and lowest targets is 497.2%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TWST.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 15% |
| Buy | 7 | 54% |
| Hold | 3 | 23% |
| Sell | 1 | 8% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $36.00 | -76.09% |
| Average target | $133.75 | -11.17% |
| High target | $215.00 | +42.80% |